Volume 26, Issue 3 (Avicenna Journal of Clinical Medicine-Autumn 2019)                   Avicenna J Clin Med 2019, 26(3): 143-150 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sobhan M, Khosravi S, Moradi A. Assessing the Prevalence of Type 2 Diabetes in Patients with Psoriasis Referred to Sina Hospital, Hamadan, Iran. Avicenna J Clin Med. 2019; 26 (3) :143-150
URL: http://sjh.umsha.ac.ir/article-1-1940-en.html
1- Assistant Professor, Department of Dermatology, Psoriasis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran , mreza_sobhan@yahoo.com
2- General Practitioner, Hamadan University of Medical Sciences, Hamadan, Iran
3- Faculty Member, Department of Community Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract:   (2703 Views)
Background and Objective: Psoriasis is one of the most common skin diseases affecting 2-4% of the population. Based on the related literature, patients with psoriasis are at increased risk of developing type 2 diabetes. The present study aimed to compare the patients with psoriasis to healthy individuals in terms of prevalence of diabetes.
Materials and Methods: This cross-sectional case-control study was carried out in Sina Hospital, Hamadan, Iran. A total of 35 patients with psoriasis were allocated to the case group and 35 healthy subjects who were comparable in terms of age and gender were assigned to the control group. All participants were examined concerning fasting plasma glucose (FPG) and body mass index. In both groups, the FPG≥126 mg/dl indicated diabetes. The collected data were analyzed in SPSS software (version 16.0; SPSS Inc. Chicago, IL). A p-value less than 0.05 was considered statistically significant.
Results: In each group, 19 individuals (54.3%) were male. Mean age in case group was 43±11.5 and in controls was 45.1±12.8 (p-value=0.481). The mean Psoriasis Area and Severity Index (PASI) of the patients was 20.6±12.7 (1.4 to 49.8). The most frequent severity of psoriasis regarding PASI was moderate including 16 patients (45.7%). The mean FPG in the patients was 108±33.6 and in controls 99.6±20.5mg/dl (P=0.755).Eight patients (22.9%) had diabetes while only 3 healthy controls (8.6%) had it (P=0.188). Multivariate logistic regression analysis demonstrated that psoriasis patients with the same gender, BMI and age have almost 4- fold increased risk of developing diabetes rather than healthy controls (P=0.08). As evidenced by the obtained results, eight patients with psoriasis (22.9%) suffered from diabetes, whereas only three (8.6%) of them had diabetes in the control group (P=0.188). Multivariate logistic regression analysis demonstrated that patients with psoriasis had almost 4-fold increased risk of developing diabetes, compared to healthy people (P=0.08).
Conclusion: Based on the findings of the current study, the probable association between type 2 diabetes and psoriasis should be taken into account given hyperglycemia in patients with psoriasis.
Full-Text [PDF 1088 kb]   (399 Downloads)    
Type of Study: Original | Subject: Dermatology

References
1. Menter A, Gottlieb CA, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol.2008;58(5):826-50. PMID: 18423260 DOI: 10.1016/j.jaad.2008.02.039
2. Schwandt A, Bergis D, Dappa A, Ebner S, Jehle PM, Koppen S. Psoriasis and diabetes: A multicenter study in 222078 type 2 diabetes patients reveals high levels of depression. J Diabetes Res. 2015;2015:792968. PMID: 26357664 DOI: 10.1155/2015/792968
3. Elder DE. Histopathology of the skin. 10th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. P. 174.
4. Salihbegoric EM, Hadzigrahic N, Cickusic AJ. Psoriasis and metabolic syndrome. Med Arch. 2015;69(2):85-7. PMID: 26005254 DOI: 10.5455/medarh.2015.69.85-87
5. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine. New York: McGraw-Hill Professional Publishing; 2012. P. 3003.
6. Gyldenlove M, Storgaard H, Holst JJ, Vilsboll T, Knope FK, Skov L. Patients with psoriasis are insulin resistant. J Am Acad Dermatol. 2015;72(4):599-605. PMID: 25653028 DOI: 10.1016/j.jaad.2015.01.004
7. Baeta IG, Bittencourt FV, Gontijo B, Goulart EM. Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol. 2014;89(5):735-44. PMID: 25184912 DOI: 10.1590/abd1806-4841.20142874
8. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol. 2010;37(2):146-55. PMID: 20175849 DOI: 10.1111/j.1346-8138.2009.00777.x
9. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(12):1729-35. PMID: 21905258 DOI: 10.1002/acr.20627
10. Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology. 2008;217(1):27-37. PMID: 18349542 DOI: 10.1159/000121333
11. Jakob L, Kostev K. Psoriasis risk in patients with type 2 diabetes in German primary care practices. Prime Care Diabetes. 2017;11(1):52-6. PMID: 27460887 DOI: 10.1016/j.pcd.2016.07.002
12. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systemic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654-62. DOI: 10.1016/j.jaad.2012.08.015
13. Farshchian M, Ansar A, Sobhan MR, Torabian S. Psoriasis and risk factors of metabolic syndrome: A case-control study. Dermatol Cosmet. 2013;4(1):10-8.
14. Nisa N, Qasi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venerol Leprol. 2010;76(6):662-5. DOI: 10.4103/0378-6323.72462
15. Cohen AD1, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venerol. 2008;22:585-9. PMID: 18331320 DOI: 10.1111/j.1468-3083.2008.02636.x
16. Pereira RR, Amladi ST, Varthakavi PK. A study of the prevalence of diabetes, insulin resistance, lipid abnormalities and cardiovascular risk factors in patients with chronic plaque psoriasis. Indian J Dermatol. 2011;56(5):520-6. PMID: 22121269 DOI: 10.4103/0019-5154.87144
17. Shalom G, Shapiro J, Dreiher J, Nathan A, Freud T, Comaneshter D, et al. Glycemic control in patients with diabetes and concomitant psoriasis. Br J Dermatol. 2016;175(2):428-30. PMID: 26991639 DOI: 10.1111/bjd.14545
18. Stern RS. Psoriasis is not a useful independent risk factor for cardiovascular disease. J Invest Dermatol. 2010;130(4):917-9. PMID: 20231828 DOI: 10.1038/jid.2009.446
19. Kim GW, Park HJ, Kim HS, Kim SH, Ko HC, Kim BS, et al. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol. 2012;24(1):11-5. PMID: 22363149 DOI: 10.5021/ad.2012.24.1.11
20. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527-34. PMID: 16365253 DOI: 10.1001/archderm.141.12.1527
21. Lønnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Association of psoriasis with the risk for type 2 diabetes mellitus and obesity. J Am Acad Dermatol. 2016;152(7):761-7. PMID: 27120802 DOI: 10.1001/jamadermatol.2015.6262
22. Kothiwala SK, Khanna N, Tandon N, Naik N, Sharma VK, Sharma S, et al. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: a hospital- based cross- sectional study. Indian J Dermatol Venerol Leprol. 2016;82(5):510-8. PMID: 27297282 DOI: 10.4103/0378-6323.183638

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 All Rights Reserved | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb